1. Home
  2. Analysis
  3. Sudafed
  4. Ezetimibe

Sudafed and Ezetimibe drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 14 people who take Sudafed and Ezetimibe. Common interactions include pruritus among females, and adrenal insufficiency among males.

The phase IV clinical study analyzes what interactions people who take Sudafed and Ezetimibe have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 24, 2023

14 people who take Sudafed and Ezetimibe together, and have interactions are studied.

What is Sudafed?

Sudafed has active ingredients of pseudoephedrine hydrochloride. It is used in nasal congestion. Currently, eHealthMe is studying from 12,472 Sudafed users.

What is Ezetimibe?

Ezetimibe has active ingredients of ezetimibe. It is used in high blood cholesterol. Currently, eHealthMe is studying from 26,046 Ezetimibe users.

Number of Sudafed and Ezetimibe reports submitted per year:

Sudafed and Ezetimibe drug interactions.

Common Sudafed and Ezetimibe drug interactions by gender *:

female:

  1. Pruritus
  2. Urticaria
  3. Abdominal discomfort
  4. Blood iron decreased
  5. Decreased appetite
  6. Dizziness
  7. Fatigue
  8. Hip arthroplasty
  9. Insomnia
  10. Osteoarthritis

male:

  1. Adrenal insufficiency
  2. Chronic kidney disease
  3. Non-cardiac chest pain
  4. Pleural effusion
  5. Pulmonary haemorrhage
  6. Renal failure
  7. Renal injury
  8. Cough
  9. Death
  10. Dysgeusia

Common Sudafed and Ezetimibe drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Dysgeusia
  2. Gingival bleeding

40-49:

  1. Hip arthroplasty
  2. Osteoarthritis
  3. Osteonecrosis
  4. Pain
  5. Urinary incontinence

50-59:

n/a

60+:

  1. Fatigue
  2. Pruritus
  3. Dyspnoea
  4. Gastrooesophageal reflux disease
  5. Insomnia
  6. Non-cardiac chest pain
  7. Pleural effusion
  8. Pulmonary haemorrhage
  9. Renal failure
  10. Renal injury

Common conditions people have *:

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 21.43%
  2. Hypersensitivity: 3 people, 21.43%
  3. Fungal Infection: 2 people, 14.29%
  4. Prostate Cancer: 2 people, 14.29%
  5. Primary Immunodeficiency Syndrome: 2 people, 14.29%
  6. Bronchial Hyperreactivity: 2 people, 14.29%
  7. Nasal Discomfort: 2 people, 14.29%
  8. Immunodeficiency Common Variable: 2 people, 14.29%
  9. Itching: 2 people, 14.29%
  10. Depression: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Sudafed and Ezetimibe?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drug side effects by duration, gender and age:

Common Sudafed drug interactions:

Browse interactions between Sudafed and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Ezetimibe drug interactions:

Browse interactions between Ezetimibe and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on pseudoephedrine hydrochloride and ezetimibe (the active ingredients of Sudafed and Ezetimibe, respectively), and Sudafed and Ezetimibe (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Sudafed and Ezetimibe.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.